Gregory J. Divis's most recent trade in Avadel Pharmaceuticals plc - ADR was a trade of 600,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 12, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Avadel Pharma PLC (ADR) | Gregory J. Divis | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Feb 2026 | 600,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Avadel Pharma PLC (ADR) | Gregory J. Divis | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Feb 2026 | 500,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Avadel Pharma PLC (ADR) | Gregory J. Divis | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Feb 2026 | 400,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Avadel Pharma PLC (ADR) | Gregory J. Divis | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Feb 2026 | 350,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Avadel Pharma PLC (ADR) | Gregory J. Divis | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Feb 2026 | 310,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Avadel Pharma PLC (ADR) | Gregory J. Divis | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Feb 2026 | 310,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Avadel Pharma PLC (ADR) | Gregory J. Divis | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 21.00 per share. | 12 Feb 2026 | 211,105 | 0 (0%) | 0% | 21 | 4,433,205 | Ordinary Shares |
| Avadel Pharma PLC (ADR) | Gregory J. Divis | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Feb 2026 | 150,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Avadel Pharma PLC (ADR) | Gregory J. Divis | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Feb 2026 | 100,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Avadel Pharma PLC (ADR) | Gregory J. Divis | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Feb 2026 | 100,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Avadel Pharma PLC (ADR) | Gregory J. Divis | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Feb 2026 | 50,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Avadel Pharma PLC (ADR) | Gregory J. Divis | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 21.00 per share. | 12 Feb 2026 | 10,000 | 0 (0%) | 0% | 21 | 210,000 | Ordinary Shares |
| Avadel Pharma PLC (ADR) | Gregory J. Divis | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2025 | 310,000 | 310,000 | - | - | Stock Option (Right to Buy) | |
| Avadel Pharma PLC (ADR) | Gregory J. Divis | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2025 | 52,000 | 211,100 (0%) | 0% | 0 | Ordinary Shares | |
| Avadel Pharma PLC (ADR) | Gregory J. Divis | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 9.98 per share. | 06 Dec 2024 | 9,598 | 9,598 (0%) | 0% | 10.0 | 95,759 | Ordinary Shares |
| Avadel Pharma PLC (ADR) | Gregory J. Divis | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 9.82 per share. | 06 Dec 2024 | 402 | 10,000 (0%) | 0% | 9.8 | 3,948 | Ordinary Shares |
| Avadel Pharma PLC (ADR) | Gregory J. Divis | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2024 | 600,000 | 600,000 | - | - | Stock Option (Right to Buy) | |
| Jaguar Health Inc | Gregory J. Divis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2022 | 12,133 | 0 | - | - | Restricted stock units | |
| Jaguar Health Inc | Gregory J. Divis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2022 | 12,133 | 12,133 (0%) | 0% | - | Common Stock | |
| Jaguar Health Inc | Gregory J. Divis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2022 | 85,900 | 85,900 | - | - | Restricted stock units | |
| Jaguar Health Inc | Gregory J. Divis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 72,750 | 72,750 | - | - | Stock option (right to buy) | |
| Jaguar Health Inc | Gregory J. Divis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 36,400 | 36,400 | - | - | Restricted stock units |